Clinical trial · Observational
Development of a Platform for the Clinical Implementation of Precision Oncology in the Central-Southern Regions of Italy (COESIT)
NCT06894823CI-TRIAL-00087630recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
COESIT aims to establish a network of reference laboratories in the central-southern regions of Italy for the genetic and molecular characterization of tumors, with the goal of implementing precision and personalized oncology in clinical practice.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Neoplasm | Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (5)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Creation of a bioinformatics network among the participating institutions. | Other | — | UNRESOLVED |
| Creation of a laboratory network | Other | — | UNRESOLVED |
| Development of a platform for the collection of clinicopathological and genetic-molecular data. | Other | — | UNRESOLVED |
| Identification of prognostic and predictive factors for the implementation of precision oncology strategies based on genomic profiling. | Other | — | UNRESOLVED |
| Mapping of genomic alterations | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Improvement of diagnostic precision in oncology based on advanced molecular profiling tools.
- timeFrame
- 4 years
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Cancer patients * Patients from the central-southern regions Exclusion Criteria: \-
References
Publications (0)
Data not yet available
No reference posted for this study.